Zimmer Biomet (NYSE: ZBH) announced that it received FDA breakthrough device designation for its iodine-treated total hip ...
TipRanks on MSN
Zimmer Biomet’s Knee Implant Study: A Market Game-Changer?
Zimmer Biomet Holdings (($ZBH)) announced an update on their ongoing clinical study. The Persona OsseoTi Keel Compatibility Study, officially ...
Zimmer Biomet Holdings (($ZBH)) announced an update on their ongoing clinical study. Study Overview: Zimmer Biomet Holdings is conducting a study ...
Adoption of immediate-load protocols is rising, enabled by nano-textured surface coatings that accelerate osseointegration ...
Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting
Company to Spotlight Comprehensive Hip & Knee Portfolios and Latest Advancements in Robotics, Including the mBôs™ System Following Recent Acquisition ...
ZBH's Q3 results on Nov. 5 may show solid gains, driven by hip, knee, and S.E.T. segment growth and recent product approvals.
I2Pure, a leader in molecular iodine technology, today celebrates Zimmer Biomet’s recent achievement in receiving Japan's Pharmaceutical and Medical Devices Agency (PMDA) approval for orthopedic ...
ASHBURN, Va., October 06, 2025--(BUSINESS WIRE)--I2Pure, a leader in molecular iodine technology, today celebrates Zimmer Biomet’s recent achievement in receiving Japan's Pharmaceutical and Medical ...
Dr. Jonathan M. Vigdorchik Named Chief Medical Technology Advisor, Adult Reconstruction and Hip Implants Dr. Anand M. Murthi Appointed Chief Medical Advisor, Shoulder, Sports, Extremities, and Trauma ...
Dr. Jonathan M. Vigdorchik Named Chief Medical Technology Advisor, Adult Reconstruction and Hip Implants Dr. Anand M. Murthi Appointed Chief Medical Advisor, Shoulder, Sports, Extremities, and Trauma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback